Research and Development

At Astellas, we believe that science is the key to unlocking the body's mysteries and we use our worldwide network of experts to expand our biomedical science knowledge and develop innovative drugs. Over 20 per cent of our staff is engaged in research and development on a global scale.

Astellas Pharma Canada, Inc. is currently involved in clinical research in Canada in five key therapeutic areas: immunosuppression in solid organ transplantation, treatment of systemic fungal infections, dermatological studies involving the treatment of atopic dermatitis and psoriasis, urology studies in overactive bladder and cardiology. Our Canadian research team actively participates in global multi-centre clinical studies conducted at university medical centres, hospitals and clinics across the country.

Astellas Pharma Canada, Inc. also supports extensive Phase 4 clinical trial research programs with Canadian investigators from all parts of the country in order to address novel and important questions related to Astellas products, as well as to gain insight on specific therapeutic issues affecting patient care and quality of life.

Research Areas

Internationally, Astellas is currently focusing our research and development efforts on six therapeutic areas:

• urology
• immunology/inflammation (transplantation)
• infectious diseases
• diabetes
• cancer
• central nervous system diseases

Research and Development Infrastructure

Astellas has research laboratories in the United States , (the Astellas Research Institute of America, Inc and a new US laboratory in Durham, North Carolina which was established through the acquisition of Urogenix, Inc.);  the Netherlands (Astellas Pharma Europe B.V.) and in Japan, in Tsukuba, Osaka and Tokyo. These facilities explore chemical compounds, natural substances and proteins to find new drug treatments. Astellas uses technologies such as genomics, bioinformatics, radiation analysis, computer analysis and image analysis to develop pharmaceuticals that are effective for patients and competitive on the global market. All products are fully tested for safety, tolerability and efficacy through clinical studies carried out in Japan, North America and Europe.

Research Collaborations for the Future

To stay ahead in research and development, Astellas pursues collaborations with external research institutes and ventures. We have also established investment vehicles that make linking with research venture companies, especially start-ups, easier. For example, Astellas Venture Capital LLC aims to identify companies with original approaches to fulfilling unmet medical needs and support them through equity investments.